SL Science Holding Limited (SLBT)
Nasdaq: SLBT · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2025
Who owns SL Science Holding Limited
As filed with the SECHolders of 5% or more
1
Ching-Dong Wang holds 59.5% of Ordinary Shares, par value $0.00001 per share, as its SCHEDULE 13D/A filed Oct 1, 2026 says.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Ching-Dong Wang
SCHEDULE 13D/A · filed Oct 1, 2026 · Ordinary Shares, par value $0.00001 per share · 59.5% in Jun 18, 2026
What SLBT reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 20-F filed Jun 18, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$10.33Tbought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 9 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Wang Ching-Dong | Chief Executive Officer | 0 | $0 | 0 | 1 | $10.33T |